Gene Therapy for X-linked Chronic Granulomatous Disease
NCT02757911
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
Las patient early withdrawed from the study
Conditions
X-Linked Chronic Granulomatous Disease
Interventions
GENETIC:
X vivo gene therapy
Sponsor
Genethon